Developments in AI for lung caner screening

Daniel Miller, MD, Medical College of Georgia, Augusta, GA, gives an overview of the emerging role of artificial intelligence (AI) in assessing the presence of lung cancer in interpulmonary nodules. The high accuracy reduces the number of unnecessary biopsies, and patients are often curious about the novelty of this technology. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.